NanoLogix Incorporated Company Profile
NanoLogix is a biotechnology company focused primarily on rapid diagnostics. Its products offer accelerated detection and identification of microorganisms. In addition to medical and homeland security applications, NanoLogix technology is applicable in pharmaceutical, industrial, veterinary and environmental testing.
News Articles
NanoLogix Inc. (OTC: NNLX), an innovator in the accelerated detection, identification and antibiotic sensitivity determination of live bacteria announces that they will exhibit th...
US Environmental Protection Agency Issues Featured News Article Covering Cooperation With NanoLogix
NanoLogix (OTC Markets: NNLX) is the subject of a featured news article released last week by the US Environmental Protection Agency. The article covers the progress of an...
NanoLogix Bacteria Detection Plates Break Longevity Records Using Anthrax as Reference Bacteria
NanoLogix Inc. (OTC: NNLX), the biotechnology company focused primarily on rapid diagnostics, is pleased to announce independent tests show extraordinary success in testing of a r...
NanoLogix Rapid Diagnostic Technologies Set to Enter Market Under FDA 510K-Exempt Status
NanoLogix (Pink Sheets: NNLX), a biotechnology innovator in the rapid detection and identification of live-threat bacteria and microorganisms, announces it will begin comme...
University of Texas Health Science Center at Houston Releases News of Successful NanoLogix Test
NanoLogix Inc. (OTC: NNLX), an innovator in the accelerated detection, identification and antibiotic sensitivity determination of live bacteria, announces that final results of a...
NanoLogix Featured in USA Today Group B Streptococcus (GBS) Awareness Campaign
HUBBARD, Ohio, Aug. 1, 2012 /PRNewswire/ -- NanoLogix (OTC Markets: NNLX), a biotechnology innovator in the rapid detection and identification of live-threat bacteria, is featured today in the U...
NanoLogix Rapid TB Detection Results Published In Journal of Microbial & Biochemical Technology
NanoLogix (OTC Markets: NNLX) An independent third-party study by one of the foremost Biomedical Research centers in the U.S. has demonstrated that NanoLogix's...
Insert inside the quotation marks in the first graph, first sentence of release: Infectious Diseases in Obstetrics and Gynecology Please also embed with the URL: ...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
NanoLogix is a biotechnology company focused primarily on rapid diagnostics. Its products offer accelerated detection and identification of microorganisms. In addition to medical...
NanoLogix is a biotechnology company focused primarily on rapid diagnostics. Its products offer accelerated detection and identification of microorganisms. In addition to national...
NanoLogix is a biotechnology company focused primarily on medical diagnostics. Its products offer accelerated detection and identification of microorganisms present in infectious and non-infectious hu...
More Information about "NanoLogix Incorporated" on BioPortfolio
We have published hundreds of NanoLogix Incorporated news stories on BioPortfolio along with dozens of NanoLogix Incorporated Clinical Trials and PubMed Articles about NanoLogix Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NanoLogix Incorporated Companies in our database. You can also find out about relevant NanoLogix Incorporated Drugs and Medications on this site too.
